QGEN Competitors & Alternatives
Compare Qiagen NV with similar stocks in the same industry
Diagnostics & Research
QGEN
Main Stock$42.04
Tradestie Score
52
Market Cap
$10.04B
P/E Ratio
22.6
Revenue Growth
0.0%
Analyst Upside
+10.1%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
|
RVTY
Revvity, Inc.
|
$149.06
|
$10.65B | 73.5 | 38 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.40
|
$9.33B | 62.5 | 57 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$286.83
|
$8.39B | - | 44 | Compare |
|
BIO
Bio-Rad Laboratories, Inc.Class A
|
$355.57
|
$8.06B | 46.1 | 53 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$174.75
|
$7.81B | - | 46 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$67.70
|
$6.00B | - | 39 | Compare |
|
BLLN
BLLN
|
$105.76
|
$5.02B | 149.9 | 35 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$18.12
|
$4.60B | 32.4 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$70.96
|
$3.26B | - | 57 | Compare |
More QGEN Analysis
Data updated: Oct 02, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry